Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Visx' European Patent claims limited:

This article was originally published in Clinica

Executive Summary

The European Patent Office has found that eight of Visx' claims for its European ophthalmological patent are invalid. The remaining claims for its Patent No 0218427 - Apparatus for Ophthalmological Surgery - were held allowable. The office upheld Summit Technology's opposition to its excimer laser competitor at the end of October (see Clinica No 679, p 14). In a second patent opposition, the European Patent Office limited the scope of Visx' claims for its European Patent No 0257836B1 on the method and apparatus for performing ophthalmic laser surgery.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT094545

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel